Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

2.

Development of peptides as potential drugs for cancer therapy.

Li ZJ, Cho CH.

Curr Pharm Des. 2010;16(10):1180-9. Review.

PMID:
20166989
3.

Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.

McGuire MJ, Gray BP, Li S, Cupka D, Byers LA, Wu L, Rezaie S, Liu YH, Pattisapu N, Issac J, Oyama T, Diao L, Heymach JV, Xie XJ, Minna JD, Brown KC.

Sci Rep. 2014 Mar 27;4:4480. doi: 10.1038/srep04480.

4.

Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents.

Loktev A, Haberkorn U, Mier W.

Curr Med Chem. 2017;24(20):2141-2155. doi: 10.2174/0929867324666170316120304. Review.

PMID:
28302013
5.

From phage display to nanoparticle delivery: functionalizing liposomes with multivalent peptides improves targeting to a cancer biomarker.

Gray BP, Li S, Brown KC.

Bioconjug Chem. 2013 Jan 16;24(1):85-96. doi: 10.1021/bc300498d. Epub 2013 Jan 7.

6.

Combinatorial discovery of tumor targeting peptides using phage display.

Landon LA, Deutscher SL.

J Cell Biochem. 2003 Oct 15;90(3):509-17.

PMID:
14523985
7.

Cancer-specific ligands identified from screening of peptide-display libraries.

Mori T.

Curr Pharm Des. 2004;10(19):2335-43. Review.

PMID:
15279612
8.

Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery.

Li ZJ, Cho CH.

J Transl Med. 2012 Sep 19;10 Suppl 1:S1. doi: 10.1186/1479-5876-10-S1-S1. Epub 2012 Sep 19. Review.

9.

Phage peptide display.

Newton J, Deutscher SL.

Handb Exp Pharmacol. 2008;(185 Pt 2):145-63. doi: 10.1007/978-3-540-77496-9_7. Review.

PMID:
18626602
10.

Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.

Bakhshinejad B, Zade HM, Shekarabi HS, Neman S.

Amino Acids. 2016 Dec;48(12):2699-2716. Epub 2016 Sep 20. Review.

PMID:
27650972
11.

Biopanning of phage displayed peptide libraries for the isolation of cell-specific ligands.

McGuire MJ, Li S, Brown KC.

Methods Mol Biol. 2009;504:291-321. doi: 10.1007/978-1-60327-569-9_18. Review.

12.

Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening.

Lee KJ, Lee JH, Chung HK, Choi J, Park J, Park SS, Ju EJ, Park J, Shin SH, Park HJ, Ko EJ, Suh N, Kim I, Hwang JJ, Song SY, Jeong SY, Choi EK.

Amino Acids. 2015 Feb;47(2):281-9. doi: 10.1007/s00726-014-1852-6. Epub 2014 Nov 1.

PMID:
25366491
13.

A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer.

Chang DK, Lin CT, Wu CH, Wu HC.

PLoS One. 2009;4(1):e4171. doi: 10.1371/journal.pone.0004171. Epub 2009 Jan 12.

14.

Landscape phages and their fusion proteins targeted to breast cancer cells.

Fagbohun OA, Bedi D, Grabchenko NI, Deinnocentes PA, Bird RC, Petrenko VA.

Protein Eng Des Sel. 2012 Jun;25(6):271-83. doi: 10.1093/protein/gzs013. Epub 2012 Apr 6.

15.

Screening peptide array library for the identification of cancer cell-binding peptides.

Kaur K, Ahmed S, Soudy R, Azmi S.

Methods Mol Biol. 2015;1248:239-47. doi: 10.1007/978-1-4939-2020-4_16. Review.

PMID:
25616337
16.
17.

Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries.

Oyama T, Rombel IT, Samli KN, Zhou X, Brown KC.

Biosens Bioelectron. 2006 Apr 15;21(10):1867-75. Epub 2006 Jan 18.

PMID:
16386888
18.

Identification of receptor ligands with phage display peptide libraries.

Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R.

J Nucl Med. 1999 May;40(5):883-8. Review.

19.
20.

Novel peptide-dendrimer conjugates as drug carriers for targeting nonsmall cell lung cancer.

Liu J, Liu J, Chu L, Wang Y, Duan Y, Feng L, Yang C, Wang L, Kong D.

Int J Nanomedicine. 2010 Dec 22;6:59-69. doi: 10.2147/IJN.S14601.

Supplemental Content

Support Center